Form 4: Twist Bioscience Director Robert Ragusa Reports Acquisition and Disposal of Common Stock

Director Robert Ragusa reports acquiring and disposing of Twist Bioscience Corp common stock on February 5, 2025.

Summary

• On February 5, 2025, Robert Ragusa, a director of Twist Bioscience Corp, acquired 4,472 shares of common stock.
• These shares were acquired at a price of $0.
• On the same day, Ragusa disposed of an unspecified amount of common stock.
• Following these transactions, Ragusa beneficially owns 23,888 shares of Twist Bioscience Corp.
• The acquisition was related to an annual equity award, which vests upon the earlier of the one-year anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date, provided the director remains a service provider.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This is a standard disclosure of stock transactions by a company insider, which is a routine part of corporate governance and transparency.

Stakeholder Impact

• The disclosure provides transparency to shareholders regarding insider transactions.

Key Dates